Invasive fungal infections pose an important threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a period of profound global environmental change and expanding at-risk populations, human-infecting pathogenic fungi are evolving resistance to all licensed systemic antifungal drugs. In this Review, we highlight the main mechanisms of antifungal resistance and explore the similarities and differences between bacterial and fungal resistance to antimicrobial control. We discuss the research and innovation topics that are needed for risk reduction strategies aimed at minimizing the emergence of resistance in pathogenic fungi. These topics include links between the environm...
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonl...
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth o...
Prior to the SARS-CoV-2 pandemic, antibiotic resistance was listed as the major global health care p...
Invasive fungal infections pose an important threat to public health and are an under-recognized com...
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonl...
The increasing number of invasive procedures and clinical therapies has led to an increase number o...
The high clinical mortality and economic burden posed by invasive fungal infections (IFIs), along wi...
Opportunistic fungal pathogens can cause a diverse range of diseases in humans. The increasing rate ...
Despite improvement of antifungal therapies over the last 30 years, the phenomenon of antifungal res...
Opportunistic fungal pathogens can cause a diverse range of diseases in humans. The increasing rate ...
Fungal pathogens are a growing threat to public health. As human immunodeficiency becomes increasing...
The emergence of drug-resistant fungi poses a major threat to human health. Despite advances in prev...
Antifungal therapy is a central component of patient management for acute and chronic mycoses. Yet, ...
Human fungal pathogens are attributable to a significant economic burden and mortality worldwide. An...
Human fungal pathogens are attributable to a significant economic burden and mortality worldwide. An...
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonl...
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth o...
Prior to the SARS-CoV-2 pandemic, antibiotic resistance was listed as the major global health care p...
Invasive fungal infections pose an important threat to public health and are an under-recognized com...
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonl...
The increasing number of invasive procedures and clinical therapies has led to an increase number o...
The high clinical mortality and economic burden posed by invasive fungal infections (IFIs), along wi...
Opportunistic fungal pathogens can cause a diverse range of diseases in humans. The increasing rate ...
Despite improvement of antifungal therapies over the last 30 years, the phenomenon of antifungal res...
Opportunistic fungal pathogens can cause a diverse range of diseases in humans. The increasing rate ...
Fungal pathogens are a growing threat to public health. As human immunodeficiency becomes increasing...
The emergence of drug-resistant fungi poses a major threat to human health. Despite advances in prev...
Antifungal therapy is a central component of patient management for acute and chronic mycoses. Yet, ...
Human fungal pathogens are attributable to a significant economic burden and mortality worldwide. An...
Human fungal pathogens are attributable to a significant economic burden and mortality worldwide. An...
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonl...
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth o...
Prior to the SARS-CoV-2 pandemic, antibiotic resistance was listed as the major global health care p...